positive allosteric NMDA receptor modulator (Peking University/Jiangsu Nhwa Pharmaceutical)

N/A

Report date: 2025/03/20 09:24:01
NME

Base Information

Drug Namepositive allosteric NMDA receptor modulator (Peking University/Jiangsu Nhwa Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressive Disorder, MajorDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPeking University
China Registration ClassN/A

Develop Information

Active CompaniesPeking UniversityJiangsu Nhwa Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepression
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A